Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NMDA receptor subunits: function and pharmacology.

Pierre Paoletti1, Jacques Neyton

  • 1Laboratoire de Neurobiologie, CNRS UMR 8544 Ecole Normale Supérieure 46 rue d'Ulm, 75005 Paris, France. paoletti@biologie.ens.fr

Current Opinion in Pharmacology
|November 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structures of the honeybee GABA<sub>A</sub> RDL receptor illuminate allosteric modulation.

Neuron·2026
Same author

Excitatory glycine receptors control ventral hippocampus synaptic plasticity and anxiety-related behaviors.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Optochemical profiling of NMDAR molecular diversity at synaptic and extrasynaptic sites.

The EMBO journal·2025
Same author

Imaging and Quantifying the Diversity of Native NMDA Receptors.

Neuroscience bulletin·2025
Same author

Editorial - Philippe Ascher (1936-2022).

Neuroscience·2025
Same author

Reversible Control of Native GluN2B-Containing NMDA Receptors with Visible Light.

ACS chemical neuroscience·2024

N-methyl-D-aspartate receptors (NMDARs) are crucial for brain function and neurological disorders. Targeting specific NMDAR subtypes offers a promising avenue for developing novel therapeutics for various brain conditions.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • N-methyl-D-aspartate receptors (NMDARs) are vital glutamate-gated ion channels in the central nervous system.
  • NMDARs are implicated in numerous neurological disorders, making them significant therapeutic targets.

Purpose of the Study:

  • To explore the molecular determinants of NMDAR subunit selectivity.
  • To identify potential therapeutic strategies by exploiting NMDAR heterogeneity for novel drug development.

Main Methods:

  • Analysis of recent structural and functional data.
  • Investigation of endogenous ligand and pharmacological agent binding sites.
  • Consideration of allosteric sites and subunit interfaces.

Main Results:

Related Experiment Videos

  • NMDARs exhibit diverse subtypes with distinct properties.
  • Molecular determinants for subunit selectivity are being elucidated, including binding sites and allosteric domains.
  • Specific NMDAR subtypes are linked to distinct disorders (e.g., NR2B in pain, NR3A in white matter injury).

Conclusions:

  • The pharmacological heterogeneity of NMDARs presents opportunities for developing subtype-selective drugs.
  • Targeting specific NMDAR subtypes could lead to novel treatments for neurological conditions.